Figure S1. Anti-PD-L1 antibody exhibited in vivo activity on GV369-CON B-cell lymphoma. A and B: CD8+T cell percentage was enhanced, as well as CD8+T cell apoptosis and Fas expression were inhibited in GV369-CON group treated with anti-PD-L1 antibody. C and D: Expression of p-AKT and p-ERK on CD8+T cells was significantly upregulated in GV369-CON group treated with anti-PD-L1 antibody. (JPG 724 kb
Figure S4. TLR7 and TLR8 expression in LN DC subsets and R848-induced activation in tumor negative B...
Figure S1. Inhibition of PI3Kα/δ improves overall survival in CT-26 tumor and is active in low and h...
Figure S3. The IFNÎł ELISPOT reactivity in LN-, LN+ and PT single cell suspensions. (PDF 380 kb
Figure S1. PD-1 expression on CD4+ and CD8+ T-cells can increase with the addition of αCSF-1R to GVA...
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Table S1. List of flow cytometry antibodies used for analysis of murine immune cell populations. Tab...
Additional file 8: Figure S8. PKP3/PD-L1 axis inhibition enhances the efficacy of anti-PD-1 therapy....
Figure S5. IL2 RNA and Bcl family RNA heatmap and protein levels. (A) Purified naïve CD8+ T-cells we...
Figure S4. Direct target engagement in primary immune cells. (A-B) CD8+ T-cells were purified from s...
(A-B). Jurkat cells were electroporated with mimics-NC and mimics-miR-708, The levels of miR-708 was...
Table S1. Immuno-phenotyping antibodies used for tumor flow cytometry. (DOCX 13 kb
Figure S1. Activation of B3Z hybridoma after co-culture with D1 DCs loaded with 1uM of indicated com...
Additional file 7: Figure S7. PKP3 increases the protein level of PD-L1. A. The relative expression ...
Table S2. List of differentiated expressed genes in control and AZD8835 treated tumors at day 7 and ...
Figure S4. Cytokine expression upon anti-CD3 stimulation: CD8+ vs. CD4+ T cells. (PDF 822 kb
Figure S4. TLR7 and TLR8 expression in LN DC subsets and R848-induced activation in tumor negative B...
Figure S1. Inhibition of PI3Kα/δ improves overall survival in CT-26 tumor and is active in low and h...
Figure S3. The IFNÎł ELISPOT reactivity in LN-, LN+ and PT single cell suspensions. (PDF 380 kb
Figure S1. PD-1 expression on CD4+ and CD8+ T-cells can increase with the addition of αCSF-1R to GVA...
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Table S1. List of flow cytometry antibodies used for analysis of murine immune cell populations. Tab...
Additional file 8: Figure S8. PKP3/PD-L1 axis inhibition enhances the efficacy of anti-PD-1 therapy....
Figure S5. IL2 RNA and Bcl family RNA heatmap and protein levels. (A) Purified naïve CD8+ T-cells we...
Figure S4. Direct target engagement in primary immune cells. (A-B) CD8+ T-cells were purified from s...
(A-B). Jurkat cells were electroporated with mimics-NC and mimics-miR-708, The levels of miR-708 was...
Table S1. Immuno-phenotyping antibodies used for tumor flow cytometry. (DOCX 13 kb
Figure S1. Activation of B3Z hybridoma after co-culture with D1 DCs loaded with 1uM of indicated com...
Additional file 7: Figure S7. PKP3 increases the protein level of PD-L1. A. The relative expression ...
Table S2. List of differentiated expressed genes in control and AZD8835 treated tumors at day 7 and ...
Figure S4. Cytokine expression upon anti-CD3 stimulation: CD8+ vs. CD4+ T cells. (PDF 822 kb
Figure S4. TLR7 and TLR8 expression in LN DC subsets and R848-induced activation in tumor negative B...
Figure S1. Inhibition of PI3Kα/δ improves overall survival in CT-26 tumor and is active in low and h...
Figure S3. The IFNÎł ELISPOT reactivity in LN-, LN+ and PT single cell suspensions. (PDF 380 kb